Literature DB >> 7471614

Transsynovial distribution of ibuprofen in arthritic patients.

J B Whitlam, K F Brown, M J Crooks, G F Room.   

Abstract

Free and total ibuprofen levels in serum and synovial fluid (SF) were determined in one male and 14 female arthritic patients (mean age 56 yr, range 19 to 77) after 400 mg three times daily for 2 days. Free drug was separated by ultrafiltration and assayed by a new highly sensitive and precise gas chromatographic-mass spectrometric technique. Total protein and albumin were assayed by automatic analyzer, and the routine serum biochemical profile obtained. Serum and SF nonesterified fatty acids (NEFAs) were methylated and assayed by gas chromatography. While both total protein and albumin levels were lower (P less than 0.01) in SF, NEFA levels did not differ (p greater than 0.05). Ibuprofen readily partitions into and binds strongly to joint fluid, the total level being about half that in serum. The ratio of total ibuprofen in SF to that in serum (x = 0.41 +/- 0.17) correlated with the albumin concentration ratio (r = 0.886) indicating that albumin binding is an important determinant of ibuprofen transsynovial distribution. A low total ibuprofen SF/serum ratio, apparent for three patients on concomitant aspirin therapy, is consistent with reports of an ibuprofen-salicylate interaction. Free ibuprofen in SF (0.192 +/- 0.086 microgram ml-1) did not differ (p greater than 0.05) from serum free levels (x = 0.251 +/- 0.139 microgram ml-1), supporting the concept of the synovial cavity as a compartment readily accessible to unbound drug species. Multiple regression analyses revealed relative independence of free concentration on total levels, and the small positive and negative influences of NEFAs and albumin concentrations. Bilirubin, uric acid, cholesterol, triglycerides, and chloride ion did not correlate with serum free concentration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7471614     DOI: 10.1038/clpt.1981.67

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

Review 1.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

2.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 3.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

4.  Concentration of azapropazone in synovial tissues and fluid.

Authors:  H Spahn; K Thabe; E Mutschler; K Tillmann; I Gikalov
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid.

Authors:  A Gaucher; P Netter; G Faure; J P Schoeller; A Gerardin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

7.  Pharmacokinetics of ibuprofen in man IV: absorption and disposition.

Authors:  J G Wagner; K S Albert; G J Szpunar; G F Lockwood
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

8.  Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.

Authors:  S Wanwimolruk; P M Brooks; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

9.  Less pain with Biatain-Ibu: initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers.

Authors:  Finn Gottrup; Bo Jørgensen; Tonny Karlsmark; R Gary Sibbald; Rytis Rimdeika; Keith Harding; Patricia Price; Vanessa Venning; Peter Vowden; Michael Jünger; Stephan Wortmann; Rita Sulcaite; Gintaris Vilkevicius; Terttu-Liisa Ahokas; Karel Ettler; Monika Arenbergerova
Journal:  Int Wound J       Date:  2007-04       Impact factor: 3.315

10.  Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings.

Authors:  D M Grennan; L Aarons; M Siddiqui; M Richards; R Thompson; C Higham
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.